KOK - MANAGER

Edit File: 1733375586.M738402P532454.premium12.web-hosting.com,S=16375,W=16571

Envelope-to: info@authorankurjain.com
Delivery-date: Thu, 05 Dec 2024 00:13:06 -0500
Date: Thu, 5 Dec 2024 05:13:05 +0000
To: info@authorankurjain.com
From: =?UTF-8?B?0JogaHR0cHM6Ly9tZWR2ZWEucnUva2F0YWxvZy8zNi4t?=
 =?UTF-8?B?dWtsYWRraS1wcm90aXZvZXBpZGVtaWNoZXNraWUtbWU=?=
 =?UTF-8?B?ZGljemluc2tpZS9rb3BpeWEtcHJvdGl2b2VwaWRlbWk=?=
 =?UTF-8?B?Y2hlc2theWEtdWtsYWRrYS3ihJYtMi5odG1sINCbIGh0dHA=?=
 =?UTF-8?B?czovL21lZHZlYS5ydS9rYXRhbG9nLzcuLWxhYm9yYXQ=?=
 =?UTF-8?B?b3Jub2Utb2JvcnVkb3ZhbmllLzcuNS4taXptZXJpdGU=?=
 =?UTF-8?B?bG55aWUtcHJpYm9yeWkva2Fsb3JpbWV0ci1la3NwZXI=?=
 =?UTF-8?B?dC0wMDFrLTIuaHRtbCAg0J/QvtC70LXQttCw0LXQsiDQn9C10YDQtdC90L4=?=
 =?UTF-8?B?0YHQvdC+0Lkg0LDQv9C/0LDRgNCw0YIg0KPQl9CYIE1pbmRyYXkgTTcgaHR0?=
 =?UTF-8?B?cHM6Ly9tZWR2ZWEucnUva2F0YWxvZy84Li1taWtyb3M=?=
 =?UTF-8?B?a29weWkvOC40Li1sYWJvcmF0b3JueWllLWktYmlvbG8=?=
 =?UTF-8?B?Z2ljaGVza2llLW1pa3Jvc2tvcHlpL2xhYm9yYXRvcm4=?=
 =?UTF-8?B?eWlqLW1pa3Jvc2tvcC1iaW9tZWQtNC10Lmh0bWwg0JTQuw==?=
 =?UTF-8?B?0Y8g0L/QvtC00LDRh9C4INCyINGC0LDQvNC+0LbQvdGOINC00LXQutC70LA=?=
 =?UTF-8?B?0YDQsNGG0LjQuCDQvdCwINCy0LLQvtC30LjQvNGD0Y4g0YLQtdGF0L3QuNC6?=
 =?UTF-8?B?0YMg0Lgg0L7QsdC+0YDRg9C00L7QstCw0L3QuNC1INC80LXQtNC40YbQuNC9?=
 =?UTF-8?B?0YHQutC+0LPQviDQvdCw0LfQvdCw0YfQtdC90LjRjyDQv9C+0YLRgNC10LE=?=
 =?UTF-8?B?0YPRjtGC0YHRjyDRgtCw0Log0LbQtTog0K3QutGB0LrQu9GO0LfQuNCy0L0=?=
 =?UTF-8?B?0YvQtSDQvtCx0L7RgNGD0LTQvtCy0LDQvdC40LUg0LjQtyDQmtC+0YDQtdC4?=
 =?UTF-8?B?IGh0dHBzOi8vbWVkdmVhLnJ1L2thdGFsb2cvMTMuLW8=?=
 =?UTF-8?B?ZnRhbG1vbG9naWNoZXNrb2Utb2JvcnVkb3ZhbmllLzE=?=
 =?UTF-8?B?My40Li10b25vbWVyeWktaS1pbmRpa2F0b3J5aS1vZnQ=?=
 =?UTF-8?B?YWxtb2xvZ2ljaGVza2llL3Rvbm9tZXRyLXZudXRyaWc=?=
 =?UTF-8?B?bGF6bm9nby1kYXZsZW5peWEtdGdkY3otMDEtcHJhLmg=?=
 =?UTF-8?B?dG1sICDQn9C10YDQtdC00L7QstGL0LUg0LrQvtGA0LXQudGB0LrQuNC1INGC?=
 =?UTF-8?B?0LXRhdC90L7Qu9C+0LPQuNC4INC/0L4g0YHQv9GA0LDQstC10LTQu9C40LI=?=
 =?UTF-8?B?0L7QuSDRhtC10L3QtSBodHRwczovL21lZHZlYS5ydS9rYXRhbG8=?=
 =?UTF-8?B?Zy8xOS4tZnVua2N6aW9uYWxuYXlhLWRpYWdub3N0aWs=?=
 =?UTF-8?B?YS8xOS42Li1nYXpvYW5hbGl6YXRvcnlpLyDQmtC+0LzQv9Cw0L0=?=
 =?UTF-8?B?0LjRjyDQstGF0L7QtNC40YIg0LIg0YfQuNGB0LvQviDQvNC40YDQvtCy0Ys=?=
 =?UTF-8?B?0YUg0LvQuNC00LXRgNC+0LIg0LIg0YHRhNC10YDQtSDQvdCw0YPQutC+0LU=?=
 =?UTF-8?B?0LzQutC40YUg0YLQtdGF0L3QvtC70L7Qs9C40Lkg0L/QviDQuNGB0L/QvtC7?=
 =?UTF-8?B?0YzQt9C+0LLQsNC90LjRjiDQodCc0JDQlCDQtNC70Y8g0LjQt9C80LXRgNC1?=
 =?UTF-8?B?0L3QuNGPINC00L7Qv9C+0LvQvdC40YLQtdC70YzQvdGL0YUg0L/QsNGA0LA=?=
 =?UTF-8?B?0LzQtdGC0YDQvtCyLCDRgtCw0LrQuNGFINC60LDQuiDRhtC10L3RgtGA0LA=?=
 =?UTF-8?B?0LvRjNC90L7QtSDQsNGA0YLQtdGA0LjQsNC70YzQvdC+0LUg0LTQsNCy0Ls=?=
 =?UTF-8?B?0LXQvdC40LUg0Lgg0LbQtdGB0YLQutC+0YHRgtGMINGB0L7RgdGD0LTQuNGB?=
 =?UTF-8?B?0YLQvtC5INGB0YLQtdC90LrQuCBodHRwczovL21lZHZlYS5ydS9rYXQ=?=
 =?UTF-8?B?YWxvZy8xNi4tc3RlcmlsaXphY3ppb25ub2Utb2JvcnU=?=
 =?UTF-8?B?ZG92YW5pZSwtZGV6aW5mZWtjeml5YS8xNi4zLi1zdGU=?=
 =?UTF-8?B?cmlsaXphdG9yeWkvc3RlcmlsaXphdG9yLXZvemR1c2g=?=
 =?UTF-8?B?bnlpai1ncC0yMC1tby5odG1sINCSINGN0YLRgyDQutCw0YLQtdCz0L7RgA==?=
 =?UTF-8?B?0LjRjiDQvNC10LTQvtCx0L7RgNGD0LTQvtCy0LDQvdC40Y8g0LLRhdC+0LQ=?=
 =?UTF-8?B?0LjRgiDRgtC10YXQvdC40LrQsCwg0LjRgdC/0L7Qu9GM0LfRg9C10LzQsNGP?=
 =?UTF-8?B?INC00LvRjyDQu9C10YfQtdC90LjRjyDQvtC/0YDQtdC00LXQu9C10L3QvdGL?=
 =?UTF-8?B?0YUg0LfQsNCx0L7Qu9C10LLQsNC90LjQuSBodHRwczovL21lZHZlYS5ydS8=?=
 =?UTF-8?B?a2F0YWxvZy8xMy4tb2Z0YWxtb2xvZ2ljaGVza29lLW8=?=
 =?UTF-8?B?Ym9ydWRvdmFuaWUvMTMuMTEuLWZpemlvdGVyYXBldnQ=?=
 =?UTF-8?B?aWNoZXNraWUtYXBwYXJhdHlpLWktcHJpc3RhdmtpL2E=?=
 =?UTF-8?B?cHBhcmF0LWFkZnQtNC1yYWR1Z2EuaHRtbCAg0Jog0L3QtdC5?=
 =?UTF-8?B?INC+0YLQvdC+0YHRj9GC0YHRjyDQu9Cw0LfQtdGA0L3Ri9C1INGD0YHRgtCw?=
 =?UTF-8?B?0L3QvtCy0LrQuCwg0L7QsdC+0YDRg9C00L7QstCw0L3QuNC1INC00LvRjyA=?=
 =?UTF-8?B?0YPQu9GM0YLRgNCw0LfQstGD0LrQvtCy0L7QuSDRgtC10YDQsNC/0LjQuCwg?=
 =?UTF-8?B?0YDQsNC30LvQuNGH0L3Ri9C1INGB0YDQtdC00YHRgtCy0LAg0LTQu9GPINC/?=
 =?UTF-8?B?0LXRgNC10LvQuNCy0LDQvdC40Y8g0LrRgNC+0LLQuCBodHRwczovL21lZHZl?=
 =?UTF-8?B?YS5ydS9rYXRhbG9nLzE2Li1zdGVyaWxpemFjemlvbm4=?=
 =?UTF-8?B?b2Utb2JvcnVkb3ZhbmllLC1kZXppbmZla2N6aXlhLzE=?=
 =?UTF-8?B?Ni40Li1zdXNoaWxueWllLXNoa2FmeWkvICDQotCw0LrQttC1IA==?=
 =?UTF-8?B?0LIg0YLQtdGA0LDQv9C10LLRgtC40YfQtdGB0LrRg9GOINCz0YDRg9C/0L8=?=
 =?UTF-8?B?0YMg0LLRhdC+0LTQuNGCINC30YPQsdC90LDRjyDRgtC10YXQvdC40LrQsCAo?=
 =?UTF-8?B?0LHQvtGA0YssINGN0LrRgdC60LDQstCw0YLQvtGA0YssINGN0LvQtdCy0LA=?=
 =?UTF-8?B?0YLQvtGA0Ysg0Lgg0LTRgC4pLiDQkiDRhtC10LvQvtC8LCDQvNC10LTQvtCx?=
 =?UTF-8?B?0L7RgNGD0LTQvtCy0LDQvdC40LUg0LTQu9GPINGC0LXRgNCw0L/QuNC4INC0?=
 =?UTF-8?B?0LXQu9GP0YIg0L3QsDog4oCUINCSINCg0L7RgdGB0LjQuCDQvNC90L7Qs9C+?=
 =?UTF-8?B?INC30LDQstC+0LTQvtCyLCDQv9C+0YHRgtGA0L7QtdC90L3Ri9GFINCyINGB?=
 =?UTF-8?B?0L7QstC10YLRgdC60L7QtSDQstGA0LXQvNGPINC4INGB0L7QstGA0LXQvNC1?=
 =?UTF-8?B?0L3QvdGL0YUsINC90LAg0LrQvtGC0L7RgNGL0YUg0LzQvtC20L3QviDQstGL?=
 =?UTF-8?B?0L/Rg9GB0LrQsNGC0Ywg0Lgg0LLRi9C/0YPRgdC60LDQtdGC0YHRjyDQvtCx?=
 =?UTF-8?B?0L7RgNGD0LTQvtCy0LDQvdC40LUg0LTQvtGB0YLQvtC50L3QvtCz0L4g0YM=?=
 =?UTF-8?B?0YDQvtCy0L3Rjywg0L3QsNC/0YDQuNC80LXRgCwg0LTQu9GPINGE0YPQvdC6?=
 =?UTF-8?B?0YbQuNC+0L3QsNC70YzQvdC+0Lkg0LTQuNCw0LPQvdC+0YHRgtC40LrQuCwg?=
 =?UTF-8?B?0YDQtdC90YLQs9C10L3QvtCy0YHQutC+0LUsINC+0L/QtdGA0LDRhtC40L4=?=
 =?UTF-8?B?0L3QvdC+0LUg0Lgg0L7QsdGJ0LXQsdC+0LvRjNC90LjRh9C90L7QtSBodHRw?=
 =?UTF-8?B?czovL21lZHZlYS5ydS9rYXRhbG9nLzEzLi1vZnRhbG0=?=
 =?UTF-8?B?b2xvZ2ljaGVza29lLW9ib3J1ZG92YW5pZS8xMy4xMS4=?=
 =?UTF-8?B?LWZpemlvdGVyYXBldnRpY2hlc2tpZS1hcHBhcmF0eWk=?=
 =?UTF-8?B?LWktcHJpc3RhdmtpLyAg0JIg0L/QvtGB0LvQtdC00L3QtdC1INCy0YDQtdC8?=
 =?UTF-8?B?0Y8g0L/RgNCw0LLQuNGC0LXQu9GM0YHRgtCy0L7QvCDQoNCkINC/0YDQuNC9?=
 =?UTF-8?B?0LjQvNCw0Y7RgtGB0Y8g0LHQvtC70LXQtSDQttC10YHRgtC60LjQtSDRgtGA?=
 =?UTF-8?B?0LXQsdC+0LLQsNC90LjRjyDQv9C+INC70L7QutCw0LvQuNC30LDRhtC40Lgs?=
 =?UTF-8?B?INGN0YLQviDQtNC+0LvQttC90L4g0YHRgtC40LzRg9C70LjRgNC+0LLQsNGC?=
 =?UTF-8?B?0Ywg0L/RgNC+0LjQt9Cy0L7QtNC40YLQtdC70LXQuSDQuiDRgNCw0LfQstC4?=
 =?UTF-8?B?0YLQuNGOIGh0dHBzOi8vbWVkdmVhLnJ1L2thdGFsb2cvMTU=?=
 =?UTF-8?B?Li1yZW5nZW5vbG9naWNoZXNrb2Utb2JvcnVkb3Zhbmk=?=
 =?UTF-8?B?ZS8xNS4xLi1uZWdhdG9za29weWkvICDQn9GA0LXQutGA0LDRgdC90Ys=?=
 =?UTF-8?B?0Lwg0L7Qv9GL0YLQvtC8INGP0LLQu9GP0LXRgtGB0Y8sINC90LDQv9GA0Lg=?=
 =?UTF-8?B?0LzQtdGALCDQv9GA0LjQvNC10L3QtdC90LjQtSDQvtGE0YHQtdGC0L3Ri9GF?=
 =?UTF-8?B?INC60L7QvdGC0YDQsNC60YLQvtCyIGh0dHBzOi8vbWVkdmVhLnJ1L2th?=
 =?UTF-8?B?dGFsb2cvMTQuLXJlYW5pbWFjemlvbm5vZS1vYm9ydWQ=?=
 =?UTF-8?B?b3ZhbmllLzE0LjMuLWRlZmlicmlseWF0b3J5aS9kZWY=?=
 =?UTF-8?B?aWJyaWxseWF0b3ItcHJpbWVkaWMtZGVmaS1iLmh0bWw=?=
 =?UTF-8?B?ICDQntC00L3QsNC60L4g0L7RgtGA0LDRgdC70Lgg0LIg0YbQtdC70L7QvCA=?=
 =?UTF-8?B?0L3QtSDRhdCy0LDRgtCw0LXRgiDRhtC10LvQvtGB0YLQvdC+0Lkg0LPQvtGB?=
 =?UTF-8?B?0YPQtNCw0YDRgdGC0LLQtdC90L3QvtC5INC/0L7Qu9C40YLQuNC60Lgg0Lg=?=
 =?UTF-8?B?0LzQv9C+0YDRgtC+0LfQsNC80LXRidC10L3QuNGPINC80LXQtNC40YbQuNC9?=
 =?UTF-8?B?0YHQutC+0LPQviDQvtCx0L7RgNGD0LTQvtCy0LDQvdC40Y8g0Lgg0LzQtdC0?=
 =?UTF-8?B?0LjRhtC40L3RgdC60LjRhSDQuNC30LTQtdC70LjQuSBodHRwczovL21lZHZl?=
 =?UTF-8?B?YS5ydS9rYXRhbG9nLzEzLi1vZnRhbG1vbG9naWNoZXM=?=
 =?UTF-8?B?a29lLW9ib3J1ZG92YW5pZS8xMy4xMS4tZml6aW90ZXI=?=
 =?UTF-8?B?YXBldnRpY2hlc2tpZS1hcHBhcmF0eWktaS1wcmlzdGE=?=
 =?UTF-8?B?dmtpL2VsZWt0cm9zdGltdWx5YXRvci1lc29maS0wMS4=?=
 =?UTF-8?B?aHRtbCAg0JLQstC10LTQtdC90LjQtSDQv9GA0LXRhNC10YDQtdC90YbQuNC5?=
 =?UTF-8?B?INC00LvRjyDQu9C+0LrQsNC70YzQvdGL0YUg0L/RgNC+0LjQt9Cy0L7QtNC4?=
 =?UTF-8?B?0YLQtdC70LXQuSDQuCDQutC+0L3RgtGA0L7Qu9GMINC30LAg0L7QsdGK0LU=?=
 =?UTF-8?B?0LzQvtC8INC70L7QutCw0LvQuNC30LDRhtC40Lgg4oCUINCy0LDQttC90Ys=?=
 =?UTF-8?B?0LUsINC90L4g0L3QtSDQuNGB0LrQu9GO0YfQuNGC0LXQu9GM0L3QvtC5INGB?=
 =?UTF-8?B?0LjQu9GLINGB0YLQuNC80YPQu9GLIGh0dHBzOi8vbWVkdmVhLnJ1L2th?=
 =?UTF-8?B?dGFsb2cvMTEuLW9ibHVjaGF0ZWxpLWJha3Rlcmljemk=?=
 =?UTF-8?B?ZG55aWUvMTEuNC4tcmVjemlya3VseWF0b3J5aS1vYmw=?=
 =?UTF-8?B?dWNoYXRlbGktYmFrdGVyaWN6aWRueWllL29ibHVjaGE=?=
 =?UTF-8?B?dGVsLXJlY3ppcmt1bHlhdG9yLXJiLTA3LXlhLWZwLTA=?=
 =?UTF-8?B?MS1wZXJlZHZpemhub2ouaHRtbCAg0JTQu9GPINGB0L7Qt9C00LDQvdC4?=
 =?UTF-8?B?0Y8g0Lgg0YDQsNC30LLQuNGC0LjRjyDQvtGC0YDQsNGB0LvQuCDQv9GA0L4=?=
 =?UTF-8?B?0LjQt9Cy0L7QtNGB0YLQstCwINC80LXQtNC40YbQuNC90YHQutC+0LPQviA=?=
 =?UTF-8?B?0L7QsdC+0YDRg9C00L7QstCw0L3QuNGPINCy0LDQttC90Ysg0LLRgdC1INC3?=
 =?UTF-8?B?0LLQtdC90YzRjyDRhtC10L/QuDog0LPQvtGB0YPQtNCw0YDRgdGC0LLQtdC9?=
 =?UTF-8?B?0L3QvtC1INGA0LXQs9GD0LvQuNGA0L7QstCw0L3QuNC1LCDQstGD0LfRiyA=?=
 =?UTF-8?B?0LTQu9GPINC/0L7QtNCz0L7RgtC+0LLQutC4INC40L3QttC10L3QtdGA0L4=?=
 =?UTF-8?B?0LIsINC/0YDQvtC30YDQsNGH0L3Ri9C1INC/0LvQsNC90Ysg0L/QviDQt9Cw?=
 =?UTF-8?B?0LrRg9C/0LrQsNC8INC4INC80L7QtNC10YDQvdC40LfQsNGG0LjQuCDQm9Cf?=
 =?UTF-8?B?0KMsINGB0L/QtdGG0LjQsNC70YzQvdGL0Lkg0L3QsNC70L7Qs9C+0LLRi9C5?=
 =?UTF-8?B?INGA0LXQttC40LwsINC00L7RgdGC0LDRgtC+0YfQvdC+0LUg0LrQvtC70Lg=?=
 =?UTF-8?B?0YfQtdGB0YLQstC+INC40YHQv9GL0YLQsNGC0LXQu9GM0L3Ri9GFINC70LA=?=
 =?UTF-8?B?0LHQvtGA0LDRgtC+0YDQuNC5INC00LvRjyDQvtCx0L7RgNGD0LTQvtCy0LA=?=
 =?UTF-8?B?0L3QuNGPIGh0dHBzOi8vbWVkdmVhLnJ1L2thdGFsb2cvMTQ=?=
 =?UTF-8?B?Li1yZWFuaW1hY3ppb25ub2Utb2JvcnVkb3ZhbmllL3A=?=
 =?UTF-8?B?cmlrcm92YXRueWllLW1vbml0b3J5aS1wYWN6aWVudGE=?=
 =?UTF-8?B?LyAg0JfQtNC10YHRjCDQuNC90YLQtdGA0LXRgdC10L0g0L7Qv9GL0YIg0LE=?=
 =?UTF-8?B?0LvQuNC20LDQudGI0LXQs9C+INGB0L7RgdC10LTQsCwg0JHQtdC70L7RgNGD?=
 =?UTF-8?B?0YHRgdC40LgsINCz0LTQtSDQt9CwINC/0L7RgdC70LXQtNC90LjQtSDQtNC1?=
 =?UTF-8?B?0YHRj9GC0LjQu9C10YLQuNGPINC/0L7Rj9Cy0LjQu9C+0YHRjCDQvdC10YE=?=
 =?UTF-8?B?0LrQvtC70YzQutC+INC00LXRgdGP0YLQutC+0LIg0YHQvtCy0YDQtdC80LU=?=
 =?UTF-8?B?0L3QvdGL0YUg0L/RgNC+0LjQt9Cy0L7QtNC40YLQtdC70LXQuSDQvNC10LQ=?=
 =?UTF-8?B?0LjRhtC40L3RgdC60L7Qs9C+INC+0LHQvtGA0YPQtNC+0LLQsNC90LjRjyA=?=
 =?UTF-8?B?0L7Rh9C10L3RjCDQstGL0YHQvtC60L7Qs9C+INC60LDRh9C10YHRgtCy0LAg?=
 =?UTF-8?B?aHR0cHM6Ly9tZWR2ZWEucnUva2F0YWxvZy8xMy4tb2Y=?=
 =?UTF-8?B?dGFsbW9sb2dpY2hlc2tvZS1vYm9ydWRvdmFuaWUvMTM=?=
 =?UTF-8?B?LjExLi1maXppb3RlcmFwZXZ0aWNoZXNraWUtYXBwYXI=?=
 =?UTF-8?B?YXR5aS1pLXByaXN0YXZraS9lbGVrdHJvc3RpbXVseWE=?=
 =?UTF-8?B?dG9yLWVzb2ZpLTAxLmh0bQ==?= <subscribe@authorankurjain.com>
Reply-To: ramiraselezneva19908003@bk.ru
Subject: Newsletter Subcription
Message-ID: <e77358c387b3bef8992819c86d317c42@www.authorankurjain.com>
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit

Name: К https://medvea.ru/katalog/36.-ukladki-protivoepidemicheskie-mediczinskie/kopiya-protivoepidemicheskaya-ukladka-№-2.html
 Л https://medvea.ru/katalog/7.-laboratornoe-oborudovanie/7.5.-izmeritelnyie-priboryi/kalorimetr-ekspert-001k-2.html
  Полежаев Переносной аппарат УЗИ Mindray M7 https://medvea.ru/katalog/8.-mikroskopyi/8.4.-laboratornyie-i-biologicheskie-mikroskopyi/laboratornyij-mikroskop-biomed-4-t.html
 
Для подачи в таможню декларации на ввозимую технику и оборудование медицинского назначения потребуются так же: 
Эксклюзивные оборудование из Кореи https://medvea.ru/katalog/13.-oftalmologicheskoe-oborudovanie/13.4.-tonomeryi-i-indikatoryi-oftalmologicheskie/tonometr-vnutriglaznogo-davleniya-tgdcz-01-pra.html
  Передовые корейские технологии по справедливой цене https://medvea.ru/katalog/19.-funkczionalnaya-diagnostika/19.6.-gazoanalizatoryi/
 
Компания входит в число мировых лидеров в сфере наукоемких технологий по использованию СМАД для измерения дополнительных параметров, таких как центральное артериальное давление и жесткость сосудистой стенки https://medvea.ru/katalog/16.-sterilizaczionnoe-oborudovanie,-dezinfekcziya/16.3.-sterilizatoryi/sterilizator-vozdushnyij-gp-20-mo.html
 
В эту категорию медоборудования входит техника, используемая для лечения определенных заболеваний https://medvea.ru/katalog/13.-oftalmologicheskoe-oborudovanie/13.11.-fizioterapevticheskie-apparatyi-i-pristavki/apparat-adft-4-raduga.html
  К ней относятся лазерные установки, оборудование для ультразвуковой терапии, различные средства для переливания крови https://medvea.ru/katalog/16.-sterilizaczionnoe-oborudovanie,-dezinfekcziya/16.4.-sushilnyie-shkafyi/
  Также в терапевтическую группу входит зубная техника (боры, экскаваторы, элеваторы и др.). В целом, медоборудование для терапии делят на: 
— В России много заводов, построенных в советское время и современных, на которых можно выпускать и выпускается оборудование достойного уровня, например, для функциональной диагностики, рентгеновское, операционное и общебольничное https://medvea.ru/katalog/13.-oftalmologicheskoe-oborudovanie/13.11.-fizioterapevticheskie-apparatyi-i-pristavki/
  В последнее время правительством РФ принимаются более жесткие требования по локализации, это должно стимулировать производителей к развитию https://medvea.ru/katalog/15.-rengenologicheskoe-oborudovanie/15.1.-negatoskopyi/
  Прекрасным опытом является, например, применение офсетных контрактов https://medvea.ru/katalog/14.-reanimaczionnoe-oborudovanie/14.3.-defibrilyatoryi/defibrillyator-primedic-defi-b.html
  Однако отрасли в целом не хватает целостной государственной политики импортозамещения медицинского оборудования и медицинских изделий https://medvea.ru/katalog/13.-oftalmologicheskoe-oborudovanie/13.11.-fizioterapevticheskie-apparatyi-i-pristavki/elektrostimulyator-esofi-01.html
  Введение преференций для локальных производителей и контроль за объемом локализации — важные, но не исключительной силы стимулы https://medvea.ru/katalog/11.-obluchateli-baktericzidnyie/11.4.-reczirkulyatoryi-obluchateli-baktericzidnyie/obluchatel-reczirkulyator-rb-07-ya-fp-01-peredvizhnoj.html
  Для создания и развития отрасли производства медицинского оборудования важны все звенья цепи: государственное регулирование, вузы для подготовки инженеров, прозрачные планы по закупкам и модернизации ЛПУ, специальный налоговый режим, достаточное количество испытательных лабораторий для оборудования https://medvea.ru/katalog/14.-reanimaczionnoe-oborudovanie/prikrovatnyie-monitoryi-paczienta/
  Здесь интересен опыт ближайшего соседа, Белоруссии, где за последние десятилетия появилось несколько десятков современных производителей медицинского оборудования очень высокого качества https://medvea.ru/katalog/13.-oftalmologicheskoe-oborudovanie/13.11.-fizioterapevticheskie-apparatyi-i-pristavki/elektrostimulyator-esofi-01.html

Mobile: 81624477335

Email: ramiraselezneva19908003@bk.ru

-----

This email was sent from a contact form on http://www.authorankurjain.com